Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-04

Clinical Trial Update: Type 2 Diabetes Secondary Prevention

View source ↗

Summary

Clinical trial NCT01207349 investigating secondary prevention in Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Type 2 Diabetes | Status: COMPLETED